secwatch.observer — SEC 8-K summary
======================================

Issuer:     IMMUCELL CORP /DE/ (ICCC)
CIK:        0000811641
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0001213900-24-052706
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

ImmuCell shareholders elect all 7 directors, approve say-on-pay, ratify auditor
-------------------------------------------------------------------------------

- All 7 director nominees elected with 88% or more of votes cast (excluding broker non-votes).
- Non-binding advisory resolution on executive compensation passed with 66% of shares voted in favor.
- Ratification of Wipfli LLP as independent auditor for 2024 approved with 99.5% of shares voted.
- Over 78% of outstanding shares (6,071,108) were represented at the June 13, 2024 annual meeting.
- Broker non-votes were 1,649,057 on director elections and say-on-pay; none on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/811641/000121390024052706/0001213900-24-052706-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/811641/000121390024052706/ea0207909-8k_immucell.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-052706

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer